Edition:
United States

Insider Trading: Edwards Lifesciences Corp (EW)

EW on New York Consolidated

95.59USD
24 Mar 2017
Change (% chg)

$1.29 (+1.37%)
Prev Close
$94.30
Open
$94.29
Day's High
$96.03
Day's Low
$94.26
Volume
1,943,081
Avg. Vol
2,376,585
52-wk High
$121.75
52-wk Low
$81.12

VON SCHACK WESLEY W

Institutional Holders

% Shares Owned: 88.31%
# of Holders: 956
Total Shares Held: 187,650,433
3 Mo. Net Change: 1,330,349
# New Positions: 112
# Closed Positions: 115
# Increased Positions: 402
# Reduced Positions: 437
# Net Buyers: -35

Officers & Directors

Name Age Since Current Position

Michael Mussallem

63 2000 Chairman of the Board, Chief Executive Officer

Scott Ullem

50 2014 Chief Financial Officer, Corporate Vice President

Donald Bobo

54 2007 Corporate Vice President - Heart Valve Therapy

Catherine Szyman

49 2015 Corporate Vice President, Critical Care

Patrick Verguet

58 2004 Corporate Vice President, Europe, Middle East and Africa

Huimin Wang

59 2010 Corporate Vice President, Japan, Asia Pacific

Larry Wood

50 2007 Corporate Vice President - Transcatheter Heart Valve Therapy

Leslie Heisz

56 2016 Director

Steven Loranger

64 2016 Director

Martha Marsh

67 2015 Director

John Cardis

74 2004 Independent Director

Kieran Gallahue

52 2015 Independent Director

William Link

70 2009 Independent Director

Barbara McNeil

75 2006 Independent Director

Nicholas Valeriani

59 2014 Independent Director

Wesley von Schack

71 2012 Presiding Independent Director

David Erickson

Vice President - Investor Relations